Literature DB >> 1152504

The hemostatic mechanism after open-heart surgery. I. Studies on plasma coagulation factors and fibrinolysis in 512 patients after extracorporeal circulation.

F Bachmann, R McKenna, E R Cole, H Najafi.   

Abstract

Blood coagulation screening profiles were performed in 512 patients who underwent open-heart surgery with extracorporeal circulation. Severe coagulation disorders were found in 29 (5.6 per cent) patients. The most common abnormalities were low one-stage prothrombin time (PT) activities and impaired whole blood clot retractions. In the majority of patients the discrepancy between low PT's and normal or only slightly depressed factor II, V, VII, and X activities was explained by the presence of an inhibitor of the extrinsic system. Eight patients demonstrated the heparin rebound phenomenon but only 1 bled excessively. The pattern of severe hepatic dysfunction was found in 4 and severe depression of vitamin K-dependent factors due to oral anticoagulants in 2. Two had disseminated intravascular coagulation. Seventeen patients with normal coagulation screening profiles bled excessively postoperatively. Of these, 2 had moderate thrombocytopenia associated with a marked platelet functional abnormality. Revision of the wound in 13 revealed a surgical hemostatic defect and in 2 the cause of bleeding could not be determined.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1152504

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  10 in total

Review 1.  The hemostatic defect of cardiopulmonary bypass.

Authors:  Matthew Dean Linden
Journal:  J Thromb Thrombolysis       Date:  2003-12       Impact factor: 2.300

2.  Hemoptysis from an emphysematous bulla developing after open-heart surgery: report of a case.

Authors:  J Nakajima; M Yamamoto; Y Kotsuka; K Yagyu; M Kawauchi; H Kubota; A Furuse; T Oka
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

3.  Effect of Gabexate mesilate on postoperative blood loss in cardiovascular surgery using cardiopulmonary bypass.

Authors:  A Kohyama; R Goh; K Mori; S Yasumoto; H Kimura; H Kitahata
Journal:  J Anesth       Date:  1994-09       Impact factor: 2.078

Review 4.  Organ dysfunction after cardiopulmonary bypass. A systemic inflammatory reaction initiated by the extracorporeal circuit.

Authors:  S Westaby
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

Review 5.  Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery.

Authors:  R Davis; R Whittington
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

6.  Preoperative plateletpheresis does not reduce blood loss during cardiac surgery.

Authors:  S K Boey; B C Ong; S S Dhara
Journal:  Can J Anaesth       Date:  1993-09       Impact factor: 5.063

7.  A prospective study of the clinical benefits of prostacyclin in 554 cardiopulmonary bypass procedures.

Authors:  M Merli; B Amari; C Cattani; L Villa; M M Visigalli; A Pellegrini
Journal:  Tex Heart Inst J       Date:  1988

8.  Homologous blood use and conservation techniques for cardiac surgery in the United Kingdom.

Authors:  G N Russell; S Peterson; S J Harper; M A Fox
Journal:  BMJ       Date:  1988-11-26

9.  Predictors of blood loss in lung transplant surgery-a single center retrospective cohort analysis.

Authors:  Bastian Grande; Pascal Oechslin; Martin Schlaepfer; Burkhardt Seifert; Ilhan Inci; Isabelle Opitz; Donat R Spahn; Walter Weder; Marco Zalunardo
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

Review 10.  Hematologic and oncologic complications in the critically ill child.

Authors:  S McIntosh
Journal:  Yale J Biol Med       Date:  1984 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.